Takeshi Tomonaga

7.6k total citations
168 papers, 5.7k citations indexed

About

Takeshi Tomonaga is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, Takeshi Tomonaga has authored 168 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Molecular Biology, 31 papers in Spectroscopy and 29 papers in Oncology. Recurrent topics in Takeshi Tomonaga's work include Advanced Proteomics Techniques and Applications (31 papers), RNA Research and Splicing (19 papers) and Genomics and Chromatin Dynamics (16 papers). Takeshi Tomonaga is often cited by papers focused on Advanced Proteomics Techniques and Applications (31 papers), RNA Research and Splicing (19 papers) and Genomics and Chromatin Dynamics (16 papers). Takeshi Tomonaga collaborates with scholars based in Japan, United States and United Kingdom. Takeshi Tomonaga's co-authors include David Levens, Fumio Nomura, Jun Adachi, Kazuyuki Matsushita, Henry C. Krutzsch, Takenori Ochiai, Takashi Sutani, Mitsuhiro Yanagida, Mark Avigan and Hideaki Shimada and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Takeshi Tomonaga

163 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeshi Tomonaga Japan	40	4.4k	919	827	715	590	168	5.7k
Vladimir N. Podust United States	43	4.0k 0.9×	343 0.4×	1.1k 1.4×	763 1.1×	213 0.4×	73	5.6k
Shigeo Sato Japan	41	4.4k 1.0×	522 0.6×	1.9k 2.3×	1.0k 1.5×	262 0.4×	71	6.4k
Bent Honoré Denmark	39	3.4k 0.8×	729 0.8×	697 0.8×	523 0.7×	81 0.1×	186	5.5k
Johannes Graumann Germany	36	4.0k 0.9×	902 1.0×	521 0.6×	458 0.6×	112 0.2×	105	5.4k
Nick Totty United Kingdom	29	4.3k 1.0×	914 1.0×	851 1.0×	571 0.8×	115 0.2×	39	6.1k
Teck Yew Low Malaysia	33	3.9k 0.9×	517 0.6×	1.1k 1.3×	528 0.7×	67 0.1×	88	5.6k
Petra Van Damme Belgium	42	4.3k 1.0×	488 0.5×	2.0k 2.4×	862 1.2×	240 0.4×	117	5.7k
Dominik Mumberg Germany	38	4.2k 1.0×	981 1.1×	1.5k 1.8×	394 0.6×	515 0.9×	136	6.5k
Jianxin Gu China	37	3.2k 0.7×	499 0.5×	965 1.2×	740 1.0×	164 0.3×	200	4.8k
Lukas C. Kühn Switzerland	47	4.4k 1.0×	775 0.8×	457 0.6×	366 0.5×	387 0.7×	90	8.0k

Countries citing papers authored by Takeshi Tomonaga

Since Specialization

Citations

This map shows the geographic impact of Takeshi Tomonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Tomonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Tomonaga more than expected).

Fields of papers citing papers by Takeshi Tomonaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Tomonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Tomonaga. The network helps show where Takeshi Tomonaga may publish in the future.

Co-authorship network of co-authors of Takeshi Tomonaga

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Tomonaga. A scholar is included among the top collaborators of Takeshi Tomonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Tomonaga. Takeshi Tomonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hongo, M, Takahisa Kuga, Yuichi Abe, et al.. (2023). Phosphotyrosine proteomics in cells synchronized at monopolar cytokinesis reveals EphA2 as functioning in cytokinesis. Experimental Cell Research. 432(1). 113783–113783.

Oka, Masahiro, Yoichi Miyamoto, Jun Adachi, et al.. (2023). Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure. Cell Reports. 42(8). 112884–112884. 22 indexed citations

Adachi, Jun, Yuichi Dai, Shinji Kikuchi, et al.. (2023). In‐depth proteomics reveals the characteristic developmental profiles of early lung adenocarcinoma with epidermal growth factor receptor mutation. Cancer Medicine. 12(9). 10755–10767. 6 indexed citations

Narumi, Ryohei, Satoshi Muraoka, Junko Isoyama, et al.. (2023). Integrative analysis of cancer dependency data and comprehensive phosphoproteomics data revealed the EPHA2-PARD3 axis as a cancer vulnerability in KRAS-mutant colorectal cancer. Molecular Omics. 19(8). 624–639. 5 indexed citations

Hikita, Hayato, Sadatsugu Sakane, Ryohei Narumi, et al.. (2022). Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. PLoS ONE. 17(7). e0271020–e0271020. 7 indexed citations

Kajiwara, Kentaro, Yuichi Abe, Satoru Okuda, et al.. (2022). Src activation in lipid rafts confers epithelial cells with invasive potential to escape from apical extrusion during cell competition. Current Biology. 32(16). 3460–3476.e6. 14 indexed citations

Kinoshita, Manao, Youichi Ogawa, Natsumi Hama, et al.. (2021). Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis. Science Translational Medicine. 13(600). 53 indexed citations

Miura, Nami, Yuki Sugiura, Yuichi Abe, et al.. (2021). Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell Carcinoma. Cancers. 13(13). 3333–3333. 7 indexed citations

Nagatake, Takahiro, Koji Hosomi, Tetsuya Honda, et al.. (2020). 母体ω3ドコサペンタエン酸は,マウスにおけるTRAIL発現形質細胞様樹状細胞を介して乳児アレルギー性皮膚炎を阻害する【JST・京大機械翻訳】. Allergy. 75(8). 1935–1951. 1 indexed citations

10.

Narumi, Ryohei, Keiko Masuda, Takeshi Tomonaga, et al.. (2018). Cell-free synthesis of stable isotope-labeled internal standards for targeted quantitative proteomics. Synthetic and Systems Biotechnology. 3(2). 97–104. 16 indexed citations

11.

Adachi, Jun, et al.. (2017). TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity. Scientific Reports. 7(1). 5519–5519. 12 indexed citations

12.

Shiromizu, Takashi, Hideaki Kume, Jun Adachi, et al.. (2017). Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics. Scientific Reports. 7(1). 12782–12782. 41 indexed citations

13.

Yamaguchi, Noritaka, Chiaki Yamada, Yuji Nakayama, et al.. (2016). Tyrosine Phosphorylation of the Pioneer Transcription Factor FoxA1 Promotes Activation of Estrogen Signaling. Journal of Cellular Biochemistry. 118(6). 1453–1461. 10 indexed citations

14.

Aoyama, Kazumasa, Ryuzaburo Yuki, Sho Kubota, et al.. (2013). Formation of long and winding nuclear F-actin bundles by nuclear c-Abl tyrosine kinase. Experimental Cell Research. 319(20). 3251–3268. 21 indexed citations

15.

Matsushita, Kazuyuki, Takeshi Tomonaga, Hideaki Shimada, et al.. (2006). An Essential Role of Alternative Splicing of c-myc Suppressor FUSE-Binding Protein–Interacting Repressor in Carcinogenesis. Cancer Research. 66(3). 1409–1417. 73 indexed citations

16.

Ikeno, Masashi, Nobutaka Suzuki, Takeshi Tomonaga, et al.. (2006). Comprehensive analysis of the ICEN (Interphase Centromere Complex) components enriched in the CENP‐A chromatin of human cells. Genes to Cells. 11(6). 673–684. 171 indexed citations

17.

Takano, Shigetsugu, Hideyuki Yoshitomi, Kazuyuki Sogawa, et al.. (2006). Identification of apolipoprotein C-1 as a novel prognostic serum marker of pancreatic cancer and its expression in cancer cells. Clinical Cancer Research. 12. 1 indexed citations

18.

Matsushita, Kazuyuki, Toshinao Takenouchi, Hideaki Shimada, et al.. (2005). Strong HLA‐DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c‐myc suppression by interferon‐γin situ. Cancer Science. 97(1). 57–63. 65 indexed citations

19.

Itoga, Sakae, Fumio Nomura, Yasuhiko Makino, et al.. (2002). Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer.. PubMed. 26(8 Suppl). 15S–19S. 41 indexed citations

20.

Tomonaga, Takeshi, Hiroaki Hayashi, M. Taira, Kyoichi Isono, & Ikuo Kojima. (1994). Signaling pathway other than phosphatidylinositol turnover is responsible for constant expression of c-myc gene in primary cultures of rat hepatocytes.. PubMed. 33(3). 429–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact